Data-Driven Decision Making

The MTA's major investment in Wabtec's hybrid locomotives promises cleaner air for New York, safer work for crews, and a more reliable subway system.

A routine prenatal screen can now detect a virus that causes birth defects, offering a path to prevention and sparking calls to change medical guidelines.

With star hires and proprietary data analytics, Abacus Global Management is making an ambitious play for the booming asset-based finance sector.

A new $65 million facility for a top U.S. intelligence lab cements Maryland's role as a national security research powerhouse. Here's what it means.

LifeVantage heads to the ICR Conference to woo investors. Can its cellular health science overcome market headwinds and a volatile direct selling landscape?

Circana's new AI-powered platform, Liquid Testing, promises to slash retail testing times from months to days, helping brands avoid costly failures.

A groundbreaking Duke trial combines a novel device to lure cancer cells with targeted immunotherapy, offering real-time tracking and new hope for patients.

Forrester recognizes Teradata's vision and performance in data fabric, highlighting the critical role of autonomous AI in the future of enterprise data.

With its massive data library and AI platforms, Tempus AI prepares for a pivotal presentation. What will CEO Eric Lefkofsky reveal to investors?

Instacart's new 'Data Hub' clean room gives CPGs unprecedented, privacy-safe access to grocery data, aiming to reshape omnichannel advertising.

Newcomer Candid Therapeutics is set to unveil its T-cell engager platform at J.P. Morgan, a move that could shake up the autoimmune treatment landscape.

A Northwest Ohio jail hires Armor Health, promising AI-driven care. But the company's history of hundreds of lawsuits raises serious questions.

A new AI-powered index assigns ships a 0-5 transparency score, aiming to expose sanctions evaders and reshape maritime insurance and global trade.

A validated dry EEG headset provides a scalable, objective measure of brain plasticity, promising to accelerate drug discovery for Alzheimer's and depression.

Inspira Technologies announces a landmark deal to acquire a liquid biopsy firm, securing a $15M investment at a $180M valuation to enter the cancer market.

A new report shows nearly half of homeowners may move due to climate risk, as soaring insurance and mortgage costs redefine the American dream.

Off The Hook's new luxury division leverages AI and an integrated model to secure ~$100M in listings and close 22 deals in its explosive first quarter.

RxSight will showcase its unique post-surgery adjustable lens at J.P. Morgan, facing investor questions on growth in a competitive ophthalmology market.

A major study reveals dropping MMR vaccination rates and a surge in measles, but identifies a key window for pediatricians to prevent missed immunizations.

Nexxen doubles down on shareholder returns with a new $40M buyback, signaling deep confidence amid market volatility and a strategic push into CTV.